Preventative approaches and treatment options for COVID-19
Researchers across the world are racing to develop preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines and
Read more
monoclonal antibodies
BioMed, Utrecht University and Erasmus discover antibody blocking SARS-CoV-2 in cells
Scientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read more
Roche’s OCREVUS (ocrelizumab) can half risk of MS impairment advance
New post-hoc analysis of six years of study data for Roche’s OCREVUS (ocrelizumab) shows earlier treatment initiation nearly halves the
Read more
Altasciences completes Gimsilumab Phase I study for ARDS in COVID-19
Canadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19
Read more
EC secures €37.5 million for COVID-19 vaccine development
The European Commission (EC) received an additional €37.5 million for urgent work on COVID-19 vaccine development, treatment and diagnostics. This
Read more
Gilead to acquire immuno-oncology company Forty Seven for $4.9 Billion
Gilead to acquire clinical-stage immuno-oncology company Forty Seven for $4.9 Billion Gilead Sciences, Inc. and Forty Seven, Inc. announced that
Read more
Ibex™ Solutions Campus, Lonza Biopark, Visp, Switzerland
Lonza is building an Ibex™ Solutions campus of five state-of-the-art manufacturing complexes that deliver biopharmaceutical customers agile capability at every stage
Read more